West Pharmaceutical Services, Inc.
WSTHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, West Pharmaceutical Services, Inc. (WST) is listed under Medical Instruments & Supplies. With a market capitalization of $22.81B, it sits in large-cap territory. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$22.81B
Beta
1.17
P/E (TTM)
43.10
P/E (Fwd)
33.79
EPS (TTM)
$7.49
EPS (Fwd)
$9.55
ROE
19.1%
ROA
11.2%
Cash
$521.4M
Total Debt
$321.0M
Free CF
$275.7M
52W Change
54.2%
Annual Financials
Cash vs Debt
With $521.4M in cash and $321.0M in debt, WST maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $275.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 19.1% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.2% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $2.89B (2022) to $3.07B (2025).
As with any equity investment, WST carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence West Pharmaceutical Services, Inc.'s trajectory.